National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody MDX-060
A monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin's disease and other lymphomas, and other cancers. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:MDX-060



Previous:monoclonal antibody HuPAM4, monoclonal antibody KW-2871, monoclonal antibody L6, monoclonal antibody Lym-1, monoclonal antibody m170
Next:monoclonal antibody Me1-14 F(ab')2, monoclonal antibody Mik-beta-1, monoclonal antibody R24, monoclonal antibody RAV12, monoclonal antibody SGN-30

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov